Calculation and usage of the thyroid to background ratio on the pertechnetate thyroid scan

Area of Science:

• Veterinary Medicine
• Endocrinology
• Nuclear Medicine

Background:

• Feline hyperthyroidism is a prevalent endocrine disorder in cats.
• Radioactive iodine (131I) therapy is highly effective, with a standard dose of 148MBq (4mCi) achieving 95-98% success rates.
• The reasons for treatment failures in feline hyperthyroidism remain incompletely understood.

Purpose of the Study:

• To investigate predictors of treatment failure in hyperthyroid cats receiving a standard 148MBq (4mCi) dose of 131I.
• To evaluate the utility of thyroid scintigraphy ratios in identifying cats likely to fail treatment.
• To determine if specific scintigraphic findings can guide individualized dosing strategies for 131I therapy.

Main Methods:

• A retrospective study involving 113 hyperthyroid cats.
• All cats underwent pertechnetate thyroid scintigraphy prior to treatment with a standard 148MBq (4mCi) 131I dose.
• Calculation of thyroid to salivary gland (T:S) and thyroid to background (T:B) ratios from scintigraphy images.
• Comparison of scintigraphic ratios between cats that were successfully treated and those with treatment failure.

Main Results:

• Treatment failure occurred in 5% (6 out of 113) of cats.
• Cats experiencing treatment failure had a significantly higher median T:B ratio (13.0) compared to successfully treated cats (4.4) (P = 0.02).
• No significant difference was observed in the T:S ratios between the two groups (P = 0.2).

Conclusions:

• The T:B ratio derived from thyroid pertechnetate scintigraphy is a significant predictor of treatment failure in hyperthyroid cats.
• Cats with a higher T:B ratio are more likely to require a higher dose of 131I for successful treatment.
• This new approach using the T:B ratio can help identify cats that may benefit from adjusted 131I dosing, improving treatment outcomes.